The emerging approach of the medication represents a major advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide501055.blogpixi.com/42359568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment